Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
- 1 January 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (1) , 103-109
- https://doi.org/10.1016/s0360-3016(96)00474-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Controversies in the Nonsurgical Treatment of Stage III Non-small Cell Lung CancerAmerican Review of Respiratory Disease, 1992
- Chemotherapy Combined with Chest Irradiation for Locally Advanced Non-Small Cell Lung CancerAnnals of Internal Medicine, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Radiosensitization by Cisplatin of RIF1 Tumour Cellsin VitroInternational Journal of Radiation Biology, 1986
- Effect of cis-dichlorodiammine platinum IIand X rays on mammalian cell survivalInternational Journal of Radiation Oncology*Biology*Physics, 1981
- The effect of cis-platinum on the repair of radiation damage in plateau phase CHINESE hamster (V-79) cellsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II)International Journal of Radiation Oncology*Biology*Physics, 1979
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976